Also trades as: LEXXW (NASDAQ) · $vol 0M
LEXX NASDAQ
Lexaria Bioscience Corp.
1W: -14.6%
1M: -78.8%
3M: -66.6%
YTD: -71.5%
1Y: -80.9%
3Y: -80.6%
5Y: -97.3%
$2.88
-0.21 (-6.80%)
Weekly Expected Move ±30.1%
$1
$2
$3
$4
$4
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
11 relationships11
As Filer
counterparties named
0
As Counterparty
mentioned by others
3
Rel. Types
2021-12-16
Earliest Filing
2025-06-12
Latest Filing
partner: 8
licensee: 2
customer: 1
Counterparties (Filed by LEXX)
11 relationshipsCompanies named in LEXX's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Novotech (Australia) Pty Limited | — | partner | Partner in a clinical study project agreement change order for DehydraTECH-tirzepatide capsules. | 2025-06-12 | View |
| JonesTrading Institutional Services LLC | — | partner | Agent for the Capital on Demand Sales Agreement | 2025-02-05 | View |
| Novotech (Australia) Pty Limited | — | partner | Agreed to act as clinical research organization (CRO) for Lexaria AU's Australian clinical study. | 2024-12-18 | View |
| JonesTrading Institutional Services LLC | — | partner | Sales agent for the Company's at-the-market offering of common stock | 2024-08-22 | View |
| InClin, Inc. | — | partner | Lexaria entered into a Master Services Agreement for InClin to act as its clinical research organization for a Phase 1b | 2023-05-12 | View |
| Maxim Group LLC | MMS | partner | Placement agent for the offering of Units | 2023-05-10 | View |
| Computershare Inc. | — | partner | Warrant agent for the offering | 2023-05-10 | View |
| Computershare Trust Company, N.A. | — | partner | Warrant agent for the offering | 2023-05-10 | View |
| Premier Wellness Science Co., Ltd. | — | licensee | Entered into a definitive intellectual property license agreement with Lexaria Hemp Corp. for DehydraTECH technology rig | 2022-06-03 | View |
| Valcon Medical A/S | — | licensee | Entered into a definitive intellectual property license agreement with Lexaria Pharmaceutical Corp. for DehydraTECH tech | 2022-06-03 | View |
| SRAX, Inc. | — | customer | Agreement for SRAX to deliver paid media services in exchange for Lexaria common shares. | 2021-12-16 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-09 | Material Agreement; Unregistered Equity Sales; Regulation FD; Exhibits | Agreement | View |
| 2026-09-01 | Other Events | View | |
| 2026-08-17 | Other Events | View | |
| 2026-08-10 | Delisting Notice | View | |
| 2026-07-30 | Bylaws Amendment; Exhibits | View | |
| 2026-02-06 | Notice of Delisting or Transfer | View | |
| 2026-01-28 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-12-16 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Other Events; Fin | Agreement | View |
| 2025-09-29 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Other Events; Fin | Agreement | View |
| 2025-09-25 | Termination of Material Definitive Agreement | View | |
| 2025-06-12 | Entry into Material Definitive Agreement | Agreement | View |
| 2025-04-28 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Other Events; Fin | Agreement | View |
| 2025-02-05 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2025-01-15 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-01-03 | Departure/Election of Directors; Appointment of Officers | View | |
| 2024-12-18 | Entry into Material Definitive Agreement | Agreement | View |
| 2024-10-18 | Shareholder Nominations | View | |
| 2024-10-16 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Other Events; Fin | Agreement | View |
| 2024-10-02 | Departure/Election of Directors; Appointment of Officers | View | |
| 2024-09-05 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR